Strain and gender modulate hepatic hepcidin 1 and 2 mRNA expression in mice

Blood Cells, Molecules, and Diseases

Volumn 32, Issue 2, 2004, Pages 283-289

  Courselaud, Brice ^a   Troadec, Marie Bérengère ^a   Fruchon, Séverine ^b   Ilyin, Gennady ^a   Borot, Nicolas ^b   Leroyer, Patricia ^a   Coppin, Hélène ^b   Brissot, Pierre ^a,c   Roth, Marie Paule ^b   Loréal, Olivier ^a  

^a INSERM   (France)

^b CHU PURPAN   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

Hepcidin; Liver; Mice; MRNA expression

Indexed keywords

HEPCIDIN; HEPCIDIN 1; HEPCIDIN 2; IRON; MESSENGER RNA; PEPTIDE HORMONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; GENDER; GENETIC ANALYSIS; HEMOCHROMATOSIS; IRON BALANCE; IRON OVERLOAD; IRON STORAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TISSUE DISTRIBUTION; WILD TYPE;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; DISEASE SUSCEPTIBILITY; GENE EXPRESSION REGULATION; HEMOCHROMATOSIS; IRON; IRON OVERLOAD; LIVER; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; RNA, MESSENGER; SEX FACTORS; SPLEEN;

EID: 10744226568     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2003.11.003     Document Type: Article

References (34)

1. Krause A., Neitz S., Magert H.J., Schulz A., Forssmann W.G., Schulz-Knappe P., Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 480:2000;147-150.
2. Park C.H., Valore E.V., Waring A.J., Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 276:2001;7806-7810.
3. Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., Loréal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276:2001;7811-7819.
4. Nicolas G., Bennoun M., Devaux I., Beaumont C., Grandchamp B., Kahn A., Vaulont S. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. U. S. A. 98:2001;8780-8785.
5. Ilyin G., Courselaud B., Troadec M.B., Pigeon C., Alizadeh M., Leroyer P., Brissot P., Loréal O. Comparative analysis of mouse hepcidin 1 and 2 genes: evidence for different patterns of expression and co-inducibility during iron overload. FEBS Lett. 542:2003;22-26.
6. Fleming R.E., Sly W.S. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc. Natl. Acad. Sci. U. S. A. 98:2001;8160-8162.
7. Nicolas G., Bennoun M., Porteu A., Mativet S., Beaumont C., Grandchamp B., Sirito M., Sawadogo M., Kahn A., Vaulont S. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Natl. Acad. Sci. U. S. A. 99:2002;4596-4601.
8. Roetto A., Papanikolaou G., Politou M., Alberti F., Girelli D., Christakis J., Loukopoulos D., Camaschella C. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33:2003;21-22.
9. Feder J.N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D.A., Basava A., Dormishian F., Domingo R. Jr., Ellis M.C., Fullan A., Hinton L.M., Jones N.L., Kimmel B.E., Kronmal G.S., Lauer P., Lee V.K., Loeb D.B., Mapa F.A., McClelland E., Meyer N.C., Mintier G.A., Moeller N., Moore T., Morikang E., Wolff R.R.et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13:1996;399-408.
10. Deugnier Y.M., Loréal O., Turlin B., Guyader D., Jouanolle H., Moirand R., Jacquelinet C., Brissot P. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology. 102:1992;2050-2059.
11. Niederau C., Fischer R., Sonnenberg A., Stremmel W., Trampisch H.J., Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N. Engl. J. Med. 313:1985;1256-1262.
12. Niederau C., Fischer R., Purschel A., Stremmel W., Haussinger D., Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 110:1996;1107-1119.
13. Brissot P., Moirand R., Jouanolle A.M., Guyader D., Le Gall J.Y., Deugnier Y., David V. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria. J. Hepatol. 30:1999;588-593.
14. Olynyk J.K., Cullen D.J., Aquilia S., Rossi E., Summerville L., Powell L.W. A population-based study of the clinical expression of the hemochromatosis gene. N. Engl. J. Med. 341:1999;718-724.
15. Bulaj Z.J., Ajioka R.S., Phillips J.D., LaSalle B.A., Jorde L.B., Griffen L.M., Edwards C.Q., Kushner J.P. Disease-related conditions in relatives of patients with hemochromatosis. N. Engl. J. Med. 343:2000;1529-1535.
16. Beutler E., Felitti V.J., Koziol J.A., Ho N.J., Gelbart T. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet. 359:2002;211-218.
17. Beutler E., Felitti V.J. The clinical penetrance of hereditary hemochromatosis. Hepatology. 37:2003;711.
18. Leboeuf R.C., Tolson D., Heinecke J.W. Dissociation between tissue iron concentrations and transferrin saturation among inbred mouse strains. J. Lab. Clin. Med. 126:1995;128-136.
19. Dupic F., Fruchon S., Bensaid M., Loréal O., Brissot P., Borot N., Roth M.P., Coppin H. Duodenal mRNA expression of iron related genes in response to iron loading and iron deficiency in four strains of mice. Gut. 51:2002;648-653.
20. de Sousa M., Reimao R., Lacerda R., Hugo P., Kaufmann S.H., Porto G. Iron overload in beta 2-microglobulin-deficient mice. Immunol. Lett. 39:1994;105-111.
21. Santos M.M., de Sousa M., Rademakers L.H., Clevers H., Marx J.J., Schilham M.W. Iron overload and heart fibrosis in mice deficient for both beta2-microglobulin and Rag1. Am. J. Pathol. 157:2000;1883-1892.
22. Sproule T.J., Jazwinska E.C., Britton R.S., Bacon B.R., Fleming R.E., Sly W.S., Roopenian D.C. Naturally variant autosomal and sex-linked loci determine the severity of iron overload in beta 2-microglobulin-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 98:2001;5170-5174.
23. Dupic F., Fruchon S., Bensaid M., Borot N., Radosavljevic M., Loréal O., Brissot P., Gilfillan S., Bahram S., Coppin H., Roth M.P. Inactivation of the hemochromatosis gene differentially regulates duodenal expression of iron-related mRNAs between mouse strains. Gastroenterology. 122:2002;745-751.
24. Ahmad K.A., Ahmann J.R., Migas M.C., Waheed A., Britton R.S., Bacon B.R., Sly W.S., Fleming R.E. Decreased liver hepcidin expression in the hfe knockout mouse. Blood Cells, Mol. Dis. 29:2002;361-366.
25. Bridle K.R., Frazer D.M., Wilkins S.J., Dixon J.L., Purdie D.M., Crawford D.H., Subramaniam V.N., Powell L.W., Anderson G.J., Ram G.A. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet. 361:2003;669-673.
26. Gehrke S.G., Kulaksiz H., Herrmann T., Riedel H.D., Bents K., Veltkamp C., Stremmel W. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to serum transferrin saturation and non-transferrin-bound iron. Blood. 102:2003;371-376.
27. Nicolas G., Viatte L., Lou D.Q., Bennoun M., Beaumont C., Kahn A., Andrews N.C., Vaulont S. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat. Genet. 34:2003;97-101.
28. Barry M., Sherlock S. Measurement of liver-iron concentration in needle biopsy specimens. Lancet. 2:1971;100-103.
29. Courselaud B., Pigeon C., Inoue Y., Inoue J., Gonzalez F.J., Leroyer P., Gilot D., Boudjema K., Guguen-Guillouzo C., Brissot P., Loréal O., Ilyin G. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J. Biol. Chem. 277:2002;41163-41170.
30. Weinstein D.A., Roy C.N., Fleming M.D., Loda M.F., Wolfsdorf J.I., Andrews N.C. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood. 100:2002;3776-3781.
31. Shike H., Lauth X., Westerman M.E., Ostland V.E., Carlberg J.M., Van Olst J.C., Shimizu C., Bulet P., Burns J.C. Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge. Eur. J. Biochem. 269:2002;2232-2237.
32. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 101:2003;2461-2463.
33. Nicolas G., Chauvet C., Viatte L., Danan J.L., Bigard X., Devaux I., Beaumont C., Kahn A., Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110:2002;1037-1044.
34. Nicolas G., Viatte L., Bennoun M., Beaumont C., Kahn A., Vaulont S. Hepcidin, a new iron regulatory peptide. Blood Cells, Mol. Dis. 29:2002;327-335.